Celladon to Present at the 2014 Stem Cell Meeting on the Mesa

SAN DIEGO, Oct. 1, 2014 (GLOBE NEWSWIRE) — Celladon Corporation (Nasdaq:CLDN), a clinical-stage biotechnology company applying its leadership position in the field of gene therapy and calcium dysregulation, today announced that Krisztina Zsebo, Ph.D …

[Read the full article here]

Comments are closed.